Caisse de depot et placement du Quebec Makes New $81.37 Million Investment in CVS Health Corporation $CVS

Key Points

• Caisse de dépôt et placement du Québec acquired 786,549 CVS Health shares worth approximately $81.37 million, giving it a 0.06% stake. Institutional investors collectively own 80.66% of the company.
• Analyst sentiment remains positive: 22 analysts rate CVS a Buy and two rate it Hold, producing a “Moderate Buy” consensus and an average price target of $107.17.
• CVS Health exceeded quarterly expectations with adjusted EPS of $2.58 versus $1.87 expected and revenue of $106.1 billion. The company also pays a quarterly dividend of $0.665, equivalent to a 2.9% annual yield.

Caisse de depot et placement du Quebec acquired a new stake in CVS Health Corporation (NYSE:CVS - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 786,549 shares of the pharmacy operator's stock, valued at approximately $81,368,000. Caisse de depot et placement du Quebec owned 0.06% of CVS Health at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Kilter Group LLC purchased a new stake in CVS Health during the 2nd quarter worth approximately $27,000. Beaird Harris Wealth Management LLC boosted its stake in shares of CVS Health by 201.0% in the second quarter. Beaird Harris Wealth Management LLC now owns 292 shares of the pharmacy operator's stock worth $30,000 after acquiring an additional 195 shares during the last quarter. J.Safra Asset Management Corp purchased a new stake in shares of CVS Health during the second quarter worth approximately $30,000. Dunhill Financial LLC acquired a new position in CVS Health in the 2nd quarter valued at $32,000. Finally, Swiss RE Ltd. purchased a new position in CVS Health in the 4th quarter valued at $26,000. Hedge funds and other institutional investors own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

CVS has been the subject of a number of recent research reports. Mizuho increased their target price on shares of CVS Health from $110.00 to $115.00 and gave the company an "outperform" rating in a research report on Monday, June 8th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of CVS Health from $88.00 to $92.00 and gave the stock a "buy" rating in a research report on Thursday, May 7th. TD Cowen increased their price objective on shares of CVS Health from $105.00 to $110.00 and gave the company a "buy" rating in a report on Monday, May 11th. Robert W. Baird set a $107.00 target price on CVS Health in a report on Thursday, August 6th. Finally, DA Davidson upped their price target on CVS Health from $80.00 to $100.00 and gave the company a "buy" rating in a research report on Thursday, May 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, CVS Health has a consensus rating of "Moderate Buy" and a consensus price target of $107.17.

CVS Health Stock Performance

CVS Health stock opened at $92.88 on Friday. The firm has a 50 day simple moving average of $101.52 and a 200-day simple moving average of $89.43. The stock has a market cap of $118.79 billion, a price-to-earnings ratio of 24.57, a price-to-earnings-growth ratio of 0.86 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. CVS Health Corporation has a 1-year low of $69.51 and a 1-year high of $110.68.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 EPS for the quarter, beating the consensus estimate of $1.87 by $0.71. The firm had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business's revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, analysts expect that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 2.9%. The ex-dividend date was Thursday, July 23rd. CVS Health's payout ratio is 70.37%.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.